RPG LifeScience. Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'07
No of Months
12
12
12
Profit Before Tax
154.00
232.00
9.94
Adjustment
-17.00
-76.00
15.00
Changes In working Capital
-43.00
-26.00
-9.38
Cash Flow after changes in Working Capital
93.00
130.00
15.56
Cash Flow from Operating Activities
56.00
77.00
15.32
Cash Flow from Investing Activities
85.00
-41.00
-6.21
Cash Flow from Financing Activities
-20.00
-27.00
-28.21
Net Cash Inflow / Outflow
121.00
8.00
-19.10
Opening Cash & Cash Equivalents
28.00
19.00
27.10
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
Closing Cash & Cash Equivalent
150.00
28.00
8.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of RPG LifeScience.
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
154.2
189.59
-35.00
-18.67%
Adjustment
-17.31
95.87
-112.00
-118.06%
Changes In working Capital
-43.17
-104.45
61.00
58.67%
Cash Flow after changes in Working Capital
93.72
181.01
-88.00
-48.22%
Cash Flow from Operating Activities
56.5
138.72
-82.00
-59.27%
Cash Flow from Investing Activities
85.84
-38.18
123.00
324.83%
Cash Flow from Financing Activities
-20.58
-89.21
69.00
76.93%
Net Cash Inflow / Outflow
121.76
11.32
110.00
975.62%
Opening Cash & Cash Equivalents
28.7
23.82
5.00
20.49%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
150.46
35.14
115.00
328.17%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -27.43% vs NA in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
56.50
77.86
-27.43%






